news analysis: drugs' cost and safety fuel a fight
a debate about makena, a costly drug to prevent premature birth, revolves around the struggle between manufacturers and the government over who is best equipped to safeguard the nation's drug supply.
http://feeds.nytimes.com/click.phdo?i=54ce9ec8464e9b52e737939e2b55bbd7
2790
05 Apr 2011 05:10:05
nyt
health